A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory ConditionsByMichael T. Halpern, MD, PhD,Cynthia S. Palmer, MSc,C. Stephen Foster, MD,Ashish Pal, BS Pharm, MBA,Carmelina Battista, PharmDJune 1st 1998
